CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma-Reference-Cited by-同舟云学术

CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma

Published:2021-05-20 Issue:1 Volume:46 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Iwata Shintaro¹,Tatsumi Yasutoshi¹,Yonemoto Tsukasa²,Araki Akinobu³,Itami Makiko³,Kamoda Hiroto²,Tsukanishi Toshinori²,Hagiwara Yoko²,Kinoshita Hideyuki²,Ishii Takeshi²,Nagase Hiroki⁴,Ohira Miki¹

Affiliation:

1. Division of Oncogenomics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba 260‑8717, Japan

2. Division of Orthopedic Surgery, Chiba Cancer Center, Chuoh-ku, Chiba 260‑8717, Japan

3. Division of Surgical Pathology, Chiba Cancer Center, Chuoh-ku, Chiba 260‑8717, Japan

4. Division of Cancer Genetics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba 260‑8717, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics;Journal of Chemotherapy;2024-08-05

3. Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients;Frontiers in Oncology;2024-05-22

4. Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review;MUSCULOSKELETAL SURGERY;2024-05-06

5. Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance;International Journal of Clinical and Experimental Pathology;2024